Related Experiment Video

Updated: Aug 17, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Activation of RalA is critical for Ras-induced tumorigenesis of human cells

Kian-Huat Lim1, Antonio T Baines, James J Fiordalisi

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

Cancer Cell
|June 14, 2005
PubMed

Insights

Activation of RalA signaling is critical for Ras-mediated human cancer growth. This study shows RalA activation propagates oncogenic activity, while RalB blunts it, highlighting RalA as a key step in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ras-mediated transformation and tumorigenic growth are critical processes in human cancer.
  • Ras-related guanine nucleotide exchange factors (RalGEFs) play a role in these processes.

Purpose of the Study:

  • To investigate the specific roles of RalGEF substrates, RalA and RalB, in Ras-mediated human cancer cell transformation and tumorigenesis.
  • To identify effector proteins involved in RalGEF-mediated oncogenic signaling.

Main Methods:

  • Knockdown of RalA expression in human cancer cells.
  • Analysis of RalA activation in pancreatic cancer cell lines.
  • Investigation of effector protein binding (RalBP1 and exocyst subunits).

Main Results:

  • RalA activation propagates oncogenic activity, whereas RalB activation blunts it.
  • Oncogenic signaling requires binding of RalBP1 and exocyst subunit effector proteins.
  • Knockdown of RalA expression significantly impeded tumor formation in human cancer cells.
  • RalA was commonly activated in pancreatic cancer cell lines.

Conclusions:

  • RalA activation is a critical step in Ras-induced transformation and tumorigenesis of human cells.
  • Targeting RalA signaling may offer a therapeutic strategy for cancers characterized by Ras activation.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...